Profil
Lynn M.
Bodarky currently works at Actinium Pharmaceuticals, Inc., as Chief Business Officer from 2023.
Ms. Bodarky also formerly worked at Geron Corp., as Vice President-Business Development from 2019 to 2021, Progenics Pharmaceuticals, Inc., as Vice President-Marketing from 2004 to 2007, and HiFiBiO Inc., as Senior VP & Global Head-Business Development.
Ms. Bodarky received her Masters Business Admin degree from The Trustees of Columbia University in The City of New York and undergraduate degree from The Wharton School of the University of Pennsylvania.
Postes actifs de Lynn M. Bodarky
| Sociétés | Poste | Début |
|---|---|---|
| ACTINIUM PHARMACEUTICALS, INC. | Corporate Officer/Principal | 03/11/2023 |
Anciens postes connus de Lynn M. Bodarky
| Sociétés | Poste | Fin |
|---|---|---|
| GERON CORPORATION | Corporate Officer/Principal | 01/01/2021 |
| PROGENICS PHARMACEUTICALS, INC. | Sales & Marketing | 01/01/2007 |
HiFiBiO Inc.
HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology Operates a biotherapeutics company mobilizing the human immune system to combat disease | Corporate Officer/Principal | - |
Formation de Lynn M. Bodarky
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 6 |
|---|---|
Geron Corp.
Geron Corp. BiotechnologyHealth Technology Discovers and develops therapeutic products for cancer | Health Technology |
Progenics Pharmaceuticals, Inc.
Progenics Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and markets medicines for prostate cancer | Health Technology |
The Trustees of Columbia University in The City of New York
The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Actinium Pharmaceuticals, Inc.
Actinium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company developing targeted payload immunotherapeutic for the treatment of advanced cancers | Health Technology |
The Wharton School of the University of Pennsylvania
The Wharton School of the University of Pennsylvania Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
HiFiBiO Inc.
HiFiBiO Inc. Pharmaceuticals: MajorHealth Technology Operates a biotherapeutics company mobilizing the human immune system to combat disease | Health Technology |
















